Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2000
10/10/2000US6130218 High blood pressure
10/10/2000US6130187 Benzofuran-7-yl uracil derivatives and herbicides
10/10/2000US6130101 Fluorescent probes for use in biological samples
10/05/2000WO2000058305A1 Novel compounds
10/05/2000WO2000058300A1 Chroman derivatives
10/05/2000WO2000058296A1 Protease inhibitors
10/05/2000WO2000058295A2 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/05/2000WO2000058288A1 Pyridine-2,3-dicarboxylic acid diamides
10/05/2000WO2000058285A1 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
10/05/2000WO2000057885A1 Pharmaceutical emulsions for retroviral protease inhibitors
10/05/2000WO2000057861A2 Use of cytidine derivatives for the treatment of leukaemia
10/05/2000WO2000042026B1 Non-peptide glp-1 agonists
10/05/2000CA2368451A1 Pyridine-2,3-dicarboxylic acid diamides
10/05/2000CA2368090A1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/05/2000CA2366012A1 Methods of treating leukemia
10/05/2000CA2361366A1 Novel compounds
10/04/2000EP1041072A1 Dioxocyclopentyl hydroxamic acids
10/04/2000EP1041071A1 Methods for the preparation of coumarine derivatives
10/04/2000EP1041067A2 Use of 2-mercapto-imidazole derivatives substituted in position 4 ( or 5 ) as antioxidants
10/04/2000EP1041066A1 Steroid receptor modulator compounds and methods
10/04/2000EP1040109A1 N-phenylamide and n-pyridylamide derivatives, method of preparing them and pharmaceutical compositions containing them
10/04/2000EP1040106A1 Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists
10/04/2000EP1040103A1 Anilide derivative, production and use thereof
10/04/2000EP1040099A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals
10/04/2000EP1039884A1 A method for the prevention and treatment of stunned myocardium
10/04/2000EP0772610B1 Dihydrobenzofuranes
10/04/2000EP0766672B1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
10/04/2000EP0765311B1 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl)piperidines, tetrahydropyridines or piperazines
10/04/2000CN1268947A Process to produce 4-hydroxy-2-oxo-pyrone derivates useful as protease inhibitors
10/04/2000CN1268942A Sulfonamide compounds and medicinal use thereof
10/04/2000CN1268889A Novel process for obtg. intermediates
10/04/2000CN1268352A Method for preparing medicinal prepns. contg. 6-heterocycle-4-amino-1,3,4,5-tetrabenzo [cd] indole
10/04/2000CN1057089C Process for preparing intermediates for synthesis of antifungal agents
10/04/2000CN1057088C Benzimidazole, prepn. method and use thereof
10/04/2000CN1056958C Pesticide composition and use thereof
10/03/2000US6127554 2,4-bis[(4-amidino)phenyl]furans as anti-Pneumocystis carinii agents
10/03/2000US6127544 1-substituted-3-ureido-indolin-2-ones which exhibit selective antagonism against gastrin receptors without causing side effects attributed to cck-a receptor antagonism; such as for treatment of peptic ulcers, gastritis
10/03/2000US6127415 Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
10/03/2000US6127404 Tissue selective compounds in the treatment of endometrial proliferation
10/03/2000US6127402 5-aroylpyrrol-2-ylmethylarene derivatives
10/03/2000US6127396 Imidazoline compounds
10/03/2000US6127388 Azetidine, pyrrolidine and piperidine derivatives as 5-HT1D receptor agonists
10/03/2000US6127386 Stimulants, neurotransmitters, cholinergic agents
10/03/2000US6127379 Benzopyran, benzothiopyran and benzofuran derivatives as 5-HT4 antagonists
10/03/2000US6127375 A 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthiones for treating viral infection
10/03/2000US6127371 Endothelin receptor antagonists
10/03/2000US6127357 N-((phenyl, benzodioxinyl or N-heteroarylpiperazinyl)alkyl)-N-(N-heteroaryl)substituted carboxamides
10/03/2000US6126932 Insoluble polymer bearing pendant side chains, said side chains each terminating with the 1-(3-(1-pyrrolidinyl)-propyl)-3-ethylcarbodiimide moiety.
09/2000
09/28/2000WO2000056731A1 Novel method for producing doxazosin mesylate in a crystalline modification designated as form a
09/28/2000WO2000056729A1 Chemokine recpetor binding heterocyclic compounds
09/28/2000WO2000056728A1 Tetrahydropyran derivatives and their use as therapeutic agents
09/28/2000WO2000056727A1 Tetrahydropyran derivatives and their use as therapeutic agents
09/28/2000WO2000056722A1 2,4-diamino-1,3,5-triazines, method for producing them and their use as herbicides and plant growth regulators
09/28/2000WO2000056710A1 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors
09/28/2000WO2000056708A1 Catalytic asymmetric synthesis of chiral aziridines
09/28/2000WO2000056335A1 Methods for treating neurodegenerative disorders using aspartyl protease inhibitors
09/28/2000CA2368047A1 Chemokine receptor binding heterocyclic compounds
09/28/2000CA2367985A1 Tetrahydropyran derivatives and their use as therapeutic agents
09/28/2000CA2367920A1 2,4-diamino-1,3,5-triazines, processes for their preparation and their use as herbicides and plant growth regulators
09/28/2000CA2367903A1 Novel method for producing doxazosin mesylate in a crystalline modification designated as form a
09/28/2000CA2367112A1 Methods for treating neurodegenerative disorders using aspartyl protease inhibitors
09/27/2000EP1038873A2 Benzo(3,4)cyclobuta(1,2-c)pyrrole derivatives as inhibitors of serotonine reuptake
09/27/2000EP1038872A1 4-Phenyl-4-heteroarylpiperdine derivatives as opioid receptor ligands
09/27/2000EP1038870A1 3,3-bis(aryl)-5-((N-(un)substituted)amido)naphthopyrans, their preparation, compositions and (co)polymer matrices containing them
09/27/2000EP1037888A1 ($i(E))-3- 1-$i(N)-BUTYL- 5- 2-(2-CARBOXYPHENYL)METHOXY- 4-CHLOROPHENYL]-1$i(H)- PYRAZOL-4-YL]-2- (5- METHOXY-2,3- DIHYDROBENZOFURAN-6-YL)METHYL]- PROP-2-ENOIC ACID MONOARGININYL SALT
09/27/2000EP1037886A1 Triazine angiogenesis inhibitors
09/27/2000EP1037882A1 Substituted 2,4-diamino-1,3,5-triazines
09/27/2000EP1037881A1 Process of preparing substituted pyrimidinones
09/27/2000EP1037880A1 Retinoic acid mimetic anilides
09/27/2000CN1268140A Monocyclic L-nucleosides, analogs and uses thereof
09/27/2000CN1268134A Bis-indole derivatives having antimetastatic activity, A process for their preparation and pharmaceutical compositions containing them
09/27/2000CN1268133A 2-Aminopyridines containing fused ring substituents as NOS inhibitors
09/27/2000CN1268124A Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments
09/27/2000CN1268123A Benzimidazole derivatives
09/27/2000CN1267667A Process for producing 2-aryl-5-(perfluoroalkyl) pyrrole compound from N-[1-chlorine-1-(perfluoroalkyl) quadri group] imido aryl chlorine compound
09/27/2000CN1056834C Novel arylindazoles and their use as herbicides
09/26/2000US6124463 Treatment of affective disorder, anxiety or depression
09/26/2000US6124454 β-form tris-(2, 3-epoxypropyl)-isocyanurate crystals and process for their production
09/26/2000US6124343 For treating a patient subject to a disease state associated with a physiological detrimental excess of endothelin or a disease state associated with a pathological condition that is modulated by inhibiting endothelin
09/26/2000US6124341 Endothelin antagonists
09/26/2000US6124324 An enzyme inhibitor of reverse transcriptase for the treatment of hiv infection, including mutant, drug-sensitive, drug-resistant, and multi-drug resistant strains of hiv
09/26/2000US6124323 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
09/26/2000US6124321 An enzyme inhibitor for enhancing memory or treating or preventing alzheimer's disease
09/26/2000US6124306 Treating human immunodeficiency virus infections
09/26/2000CA2168016C Benzimidazole derivatives
09/21/2000WO2000055157A1 Method for obtaining polymorph a from doxazosine mesylate
09/21/2000WO2000055153A1 Amide derivatives
09/21/2000WO2000055152A1 Aromatic heterocyclic compounds as anti-inflammatory agents
09/21/2000WO2000055150A1 Improved process for asymmetric hydrogenation
09/21/2000WO2000055144A1 Amine derivatives as protease inhibitors
09/21/2000WO2000055141A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
09/21/2000WO2000055139A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents
09/21/2000WO2000055137A1 Compounds and methods for modulation of estrogen receptors
09/21/2000WO2000055126A2 N-cyanomethylamides as protease inhibitors
09/21/2000WO2000055125A2 N-cyanomethyl amides as protease inhibitors
09/21/2000WO2000054729A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues
09/21/2000WO2000032577A3 Substituted benzo[de]isoquinoline-1,3-diones
09/21/2000DE19912637A1 2,4-Diamino-1,3,5-triazine, Verfahren zur Herstellung und Verwendung als Herbizide und Pflanzenwachstumsregulatoren 2,4-diamino-1,3,5-triazines, to processes for preparation and use as herbicides and plant growth regulators
09/21/2000DE19912063A1 Neues Verfahren zur Herstellung von Doxazosin-Mesylat in einer als Form A bezeichneten Kristallmodifikation New process for the preparation of doxazosin mesylate in a crystal modification, referred to as Form A
09/21/2000DE19911509A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation